News
4 States Ask FDA to Lift Rules on Abortion Pill Mifepristone
FRIDAY, June 6, 2025 (HealthDay News) — Attorneys general from four states are asking the U.S. Food and Drug Administration (FDA) to lift restrictions on mifepristone, a pill used in medication abortions. The request came Thursday from top officials in California, Massachusetts, New Jersey and New York.
In response to FDA safety review of mifepristone, 4 pro-abortion states hit back
Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, attorneys general from four pro-abortion states have fired back, filing (PDF) a petition asking the U.S. regulator to lift restrictions on the treatment.
Four attorneys general filed a petition with the FDA to lift restrictions on the abortion medication mifepristone.
Food and Drug Administration Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent ...
Republicans have been laying the groundwork to undermine the safety of mifepristone for months, despite the drug's proven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback